Robyn S. Klein, Christopher A. Hunter  Immunity 

Slides:



Advertisements
Similar presentations
Neurobiology course Group 7 Ivana Mizikova Salla Kangas Henri Urpilainen.
Advertisements

Biochemical Markers in the inflammatory response Dr Claire Bethune Consultant Immunologist Derriford Hospital.
Pattern recognition receptors (PRRs)
INNATE IMMUNITY/ MUCOSAL IMMUNOLOGY REVIEW
M1 – Immunology EFFECTOR T CELL FUNCTIONS (Part I) March 27, 2009 Ronald B. Smeltz, Ph.D. Microbiology and Immunology
Therapeutic vaccines and immune-based therapies for the treatment of chronic hepatitis B: Perspectives and challenges  Marie-Louise Michel, Qiang Deng,
Kusumawadee Utispan, Sittichai Koontongkaew 
T cell mediated immunity Part II
The CD70-CD27 Axis, a New Brake in the T Helper 17 Cell Response
CD5: A New Partner for IL-6
Bridget A. Robinson, Timothy J. Nice  Immunity 
Act1, Scene Brain: Astrocytes Play a Lead Role
Bugs and Brain: How Infection Makes You Feel Blue
Aleksandra Deczkowska, Michal Schwartz  Immunity 
The Leptin Connection: Regulatory T Cells and Autoimmunity
Interferon-λ: Immune Functions at Barrier Surfaces and Beyond
The Th17 immune response in renal inflammation
Engineering T Cells to Functionally Cure HIV-1 Infection
Some DCs Are “B”etter Immunity
The Gastrointestinal Tract and AIDS Pathogenesis
T Helper 17 Cells Get the NOD
Checks and Balances: IL-23 in the Intestine
Macrophages and Therapeutic Resistance in Cancer
Unraveling the Pros and Cons of Interferon-γ Gene Regulation
The Microenvironmental Landscape of Brain Tumors
Macrophages and Therapeutic Resistance in Cancer
Offspring’s Tolerance of Mother Goes Viral
Therapeutic vaccines and immune-based therapies for the treatment of chronic hepatitis B: Perspectives and challenges  Marie-Louise Michel, Qiang Deng,
Control of Brain Development, Function, and Behavior by the Microbiome
Microglia and the Immune Pathology of Alzheimer Disease
Intracellular Pathogens and CD8+ Dendritic Cells: Dangerous Liaisons
Interleukin-33 in Tissue Homeostasis, Injury, and Inflammation
Commanding CNS Invasion: GM-CSF
Interleukin-17 Kick-Starts T Helper 1 Cell Differentiation
Jason D. Ulrich, Tien-Phat Huynh, David M. Holtzman  Neuron 
Healing Genes in the Nervous System
Volume 64, Issue 1, Pages (October 2009)
H. Zhao, A. Alam, Q. Chen, M. A. Eusman, A. Pal, S. Eguchi, L. Wu, D
Gut-Pancreatic Axis AMPlified in Islets of Langerhans
Humoral and Cell Mediated Immunity
The Role of Retinoic Acid in Tolerance and Immunity
Natural Killer Cell Memory
Dichotomous Role of Interferon-γ in Allogeneic Bone Marrow Transplant
Richard Daneman, Maria Rescigno  Immunity 
The Neurobiology of Zika Virus
Wenjun Ouyang, Jay K. Kolls, Yan Zheng  Immunity 
Old Meets New: The Interaction Between Innate and Adaptive Immunity
Tumor-Associated Macrophages: From Mechanisms to Therapy
Myeloid Cells in the Central Nervous System
Indiscriminate Memories during Infection Control
Deciphering and Reversing Tumor Immune Suppression
HIV and HLA Class I: An Evolving Relationship
Infected Cells Call Their Killers to the Scene of the Crime
Volume 28, Issue 6, Pages (June 2008)
Figure 7 VEGF as a mediator of neuroinflammatory disease
IL-7 Knocks the Socs Off Chronic Viral Infection
Figure 3 Blood–brain barrier breakdown promotes neurodegeneration
Judith Behnsen, Manuela Raffatellu  Immunity 
Mesenchymal Stromal Cells: Sensors and Switchers of Inflammation
by Jonathan Kipnis Science Volume 353(6301): August 19, 2016
Virus Infections in the Nervous System
Even Neurons Are Excited by Th17 Cells
Dendritic-Cell-Based Therapeutic Cancer Vaccines
Keeping STATs on Memory CD8+ T Cells
Development and differentiation of endothelium
Some DCs Are “B”etter Immunity
Matthew D. Weitzman, Jonathan B. Weitzman  Cell Host & Microbe 
T Helper Cell Differentiation: Understanding the Needs of Hierarchy
Stable IL-10: A New Therapeutic that Promotes Tumor Immunity
Chain of events leading to pulmonary immunopathology following HMPV infection. Chain of events leading to pulmonary immunopathology following HMPV infection.
Presentation transcript:

Protective and Pathological Immunity during Central Nervous System Infections  Robyn S. Klein, Christopher A. Hunter  Immunity  Volume 46, Issue 6, Pages 891-909 (June 2017) DOI: 10.1016/j.immuni.2017.06.012 Copyright © 2017 Terms and Conditions

Figure 1 Pathogen Mechanisms for Crossing the Blood Brain Barrier (A) The NVU is composed of astrocyte endfeet, pericytes, and endtothelial cells and the local production of type I IFNs has a major role in controlling opening of the BBB (Daniels et al., 2017; Lazear et al., 2015). Micro-organisms utilize three main mechanisms to directly transit the BBB. (B) Trans-cellular route by which viruses or infected cells directly cross through EC (Dahm et al., 2016). (C) Para-cellular route whereby the breakdown of the tight junctions allows access of infected cells or extracellular pathogens to access the peri-vascular unit (Santiago-Tirado et al., 2017; Shi et al., 2010; Vu et al., 2013). (D) Lytic mechanisms in which the ability to infect EC and lyse these cells allows pathogens to access the brain (Konradt et al., 2016). Immunity 2017 46, 891-909DOI: (10.1016/j.immuni.2017.06.012) Copyright © 2017 Terms and Conditions

Figure 2 Viral Modulation of BBB Function Viruses might impact on TJ integrity via direct and indirect mechanisms: (1) virus detection by brain endothelial TAM receptors in conjunction with type I IFN signaling enhances TJ integrity (Miner et al., 2015); (2) nonstructural protein (NS)1 secretion by flaviviruses might decrease TJ integrity, increasing barrier permeability; (3) PRR signaling during viral infection of astrocytes leads to type I IFN expression which has been shown to improve BBB function via intercellular crosstalk with brain endothelium (Daniels et al., 2014); (Pfefferkorn et al., 2015); and (4) secretion of transactivator protein (TAT) during CNS infection with HIV-1 induces pericyte expression of PDGFβ, which disrupts BBB junctional proteins and promotes pericyte migration away from the vasculature (Niu et al., 2014), (Winkler et al., 2010). Immunity 2017 46, 891-909DOI: (10.1016/j.immuni.2017.06.012) Copyright © 2017 Terms and Conditions

Figure 3 Effector Mechanisms Used by T Cells to Control CNS Infection (A) The ability of pathogen-specific CD4+ and CD8+ T cells to exit the circulation, cross the BBB, and access the parenchyma precedes the search for relevant infected CNS-specific targets. (B) The local production of IFN-γ by CD4+ and CD8+ T cells has a prominent role in the activation of STAT1 and the anti-microbial activities of astrocytes and microglia. While CD8+ T cells can interact with infected astrocytes and microglia to mediate elimination of infected cells or control of pathogen replication it is unclear whether their interactions with neurons is direct through MHC-TCR interactions or indirect through the activation of microglia. (C) The development of Th17 responses characterized by the production of IL-17 and/or GM-CSF is correlated with the development of immunopathology and the recruitment of inflammatory monocytes. Immunity 2017 46, 891-909DOI: (10.1016/j.immuni.2017.06.012) Copyright © 2017 Terms and Conditions